| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Antistio Aviz-Amador, Neyder Contreras-Puentes, Jairo Mercado-Camarg. Virtual screening using docking and molecular dynamics of cannabinoid analogs against CB Computational biology and chemistry. vol 95. 2021-12-07. PMID:34700256. |
virtual screening using docking and molecular dynamics of cannabinoid analogs against cb cannabis sativa has been attributed to different pharmacological properties. |
2021-12-07 |
2023-08-13 |
Not clear |
| Jonathan J Simone, Matthew R Green, Cheryl M McCormic. Endocannabinoid system contributions to sex-specific adolescent neurodevelopment. Progress in neuro-psychopharmacology & biological psychiatry. vol 113. 2021-12-06. PMID:34534603. |
with an increasing number of countries and states adopting legislation permitting the use of cannabis for medical purposes, there is a growing interest among health and research professionals into the system through which cannabinoids principally act, the endocannabinoid system (ecs). |
2021-12-06 |
2023-08-13 |
Not clear |
| Tibor Stark, Serena Di Martino, Filippo Drago, Carsten T Wotjak, Vincenzo Mical. Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment. Pharmacological research. vol 174. 2021-12-06. PMID:34655773. |
cannabis exerts its effects via altering signalling within the endocannabinoid system (ecs), which modulates the stress circuitry during the neurodevelopment. |
2021-12-06 |
2023-08-13 |
human |
| Erin L Martin, Aimee L McRae-Clar. Evidence for the Endocannabinoid System as a Therapeutic Target in the Treatment of Cannabis Use Disorder. Current addiction reports. vol 7. 2021-12-03. PMID:33816054. |
evidence for the endocannabinoid system as a therapeutic target in the treatment of cannabis use disorder. |
2021-12-03 |
2023-08-13 |
Not clear |
| Erin L Martin, Aimee L McRae-Clar. Evidence for the Endocannabinoid System as a Therapeutic Target in the Treatment of Cannabis Use Disorder. Current addiction reports. vol 7. 2021-12-03. PMID:33816054. |
pharmacotherapeutic supplementation may improve efficacy, and the endocannabinoid system presents a target specifically dysregulated by heavy cannabis use. |
2021-12-03 |
2023-08-13 |
Not clear |
| Stephen Emmerling, Beth Martin, Natalie Schmit. A survey of Wisconsin pharmacists about cannabinoid products: Are we ready to recommend? Journal of the American Pharmacists Association : JAPhA. vol 61. issue 6. 2021-12-03. PMID:34456146. |
in today's culture, cannabis and its cannabinoids are used for both recreational and medicinal purposes. |
2021-12-03 |
2023-08-13 |
Not clear |
| Shamema Nasrin, Christy J W Watson, Keti Bardhi, Gabriela Fort, Gang Chen, Philip Lazaru. Inhibition of UDP-Glucuronosyltransferase Enzymes by Major Cannabinoids and Their Metabolites. Drug metabolism and disposition: the biological fate of chemicals. vol 49. issue 12. 2021-12-03. PMID:34493601. |
one such interaction yet to be examined may be occurring between ugts and cannabinoids, as the legalization of recreational and medicinal cannabis and subsequent co-usage of cannabis and therapeutic drugs increases in the united states and internationally. |
2021-12-03 |
2023-08-13 |
Not clear |
| Shelly Tartakover Matalon, Shahar Azar, David Meiri, Rivka Hadar, Alina Nemirovski, Narjes Abu Jabal, Fred Meir Konikoff, Liat Drucker, Joseph Tam, Timna Naftal. Endocannabinoid Levels in Ulcerative Colitis Patients Correlate With Clinical Parameters and Are Affected by Cannabis Consumption. Frontiers in endocrinology. vol 12. 2021-12-01. PMID:34531823. |
endocannabinoid levels in ulcerative colitis patients correlate with clinical parameters and are affected by cannabis consumption. |
2021-12-01 |
2023-08-13 |
Not clear |
| Donald I Abrams, Guillermo Velasco, Chris Twelves, Ramesh K Ganju, Gil Bar-Sel. Cancer Treatment: Preclinical & Clinical. Journal of the National Cancer Institute. Monographs. vol 2021. issue 58. 2021-12-01. PMID:34850894. |
another preclinical presentation reports the effects of cannabinoids on triple-negative breast cancer cell lines and how cannabidiol may affect tumors. |
2021-12-01 |
2023-08-13 |
human |
| Gary L Ellison, L Alejandro Salicrup, Andrew N Freedman, Yali Fu, Sharon Ross, Ronald L Johnson, Alexis Bakos, Jeffrey D Whit. The National Cancer Institute and Cannabis and Cannabinoids Research. Journal of the National Cancer Institute. Monographs. vol 2021. issue 58. 2021-12-01. PMID:34850895. |
the national cancer institute and cannabis and cannabinoids research. |
2021-12-01 |
2023-08-13 |
Not clear |
| Gary L Ellison, L Alejandro Salicrup, Andrew N Freedman, Yali Fu, Sharon Ross, Ronald L Johnson, Alexis Bakos, Jeffrey D Whit. The National Cancer Institute and Cannabis and Cannabinoids Research. Journal of the National Cancer Institute. Monographs. vol 2021. issue 58. 2021-12-01. PMID:34850895. |
the landscape of both recreational and medicinal cannabis use has changed dramatically over the past decade; however, research examining the risks and benefits of cannabis and cannabinoid use has lagged significantly behind the increased media promotion and their use by the general public and cancer patients. |
2021-12-01 |
2023-08-13 |
Not clear |
| Gary L Ellison, L Alejandro Salicrup, Andrew N Freedman, Yali Fu, Sharon Ross, Ronald L Johnson, Alexis Bakos, Jeffrey D Whit. The National Cancer Institute and Cannabis and Cannabinoids Research. Journal of the National Cancer Institute. Monographs. vol 2021. issue 58. 2021-12-01. PMID:34850895. |
in addition, nci organized a virtual symposium on december 15-18, 2020, to discuss recent research findings on the use of cannabis and cannabinoids in relationship to cancer risk, prevention, and care. |
2021-12-01 |
2023-08-13 |
Not clear |
| Gary L Ellison, L Alejandro Salicrup, Andrew N Freedman, Yali Fu, Sharon Ross, Ronald L Johnson, Alexis Bakos, Jeffrey D Whit. The National Cancer Institute and Cannabis and Cannabinoids Research. Journal of the National Cancer Institute. Monographs. vol 2021. issue 58. 2021-12-01. PMID:34850895. |
specifically, the symposium sought to highlight the state of the science regarding cannabis, including the chemical constituents of cannabis (eg, cannabinoids), and cancer research involving cannabis, including cancer epidemiology, use in cancer patients, cancer biology and prevention, and preclinical and clinical cancer symptom and treatment side effect management with cannabis and cannabinoids as therapeutics. |
2021-12-01 |
2023-08-13 |
Not clear |
| Ziva D Cooper, Donald I Abrams, Steven Gust, Alejandro Salicrup, Douglas C Throckmorto. Challenges for Clinical Cannabis and Cannabinoid Research in the United States. Journal of the National Cancer Institute. Monographs. vol 2021. issue 58. 2021-12-01. PMID:34850896. |
challenges for clinical cannabis and cannabinoid research in the united states. |
2021-12-01 |
2023-08-13 |
Not clear |
| Ziva D Cooper, Donald I Abrams, Steven Gust, Alejandro Salicrup, Douglas C Throckmorto. Challenges for Clinical Cannabis and Cannabinoid Research in the United States. Journal of the National Cancer Institute. Monographs. vol 2021. issue 58. 2021-12-01. PMID:34850896. |
three primary barriers contribute to the difficulty in initiating research geared toward answering the most pressing public health questions: the us regulatory status of cannabis and cannabinoids, sources for cannabis and cannabinoid study medications, and limited funding and resources to support studies. |
2021-12-01 |
2023-08-13 |
Not clear |
| Ziva D Cooper, Donald I Abrams, Steven Gust, Alejandro Salicrup, Douglas C Throckmorto. Challenges for Clinical Cannabis and Cannabinoid Research in the United States. Journal of the National Cancer Institute. Monographs. vol 2021. issue 58. 2021-12-01. PMID:34850896. |
here, challenges and barriers to cannabis and cannabinoid research are described from the perspectives of the national institute on drug abuse, national institutes of health; the us food and drug administration; and 2 clinical researchers. |
2021-12-01 |
2023-08-13 |
Not clear |
| Ziva D Cooper, Donald I Abrams, Steven Gust, Alejandro Salicrup, Douglas C Throckmorto. Challenges for Clinical Cannabis and Cannabinoid Research in the United States. Journal of the National Cancer Institute. Monographs. vol 2021. issue 58. 2021-12-01. PMID:34850896. |
barriers specifically to studying cannabis, cannabinoids, and cancer are emphasized. |
2021-12-01 |
2023-08-13 |
Not clear |
| Michelle Sexton, Jose M Garcia, Aminah Jatoi, Carey S Clark, Mark S Wallac. The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids. Journal of the National Cancer Institute. Monographs. vol 2021. issue 58. 2021-12-01. PMID:34850897. |
the management of cancer symptoms and treatment-induced side effects with cannabis or cannabinoids. |
2021-12-01 |
2023-08-13 |
Not clear |
| Michelle Sexton, Jose M Garcia, Aminah Jatoi, Carey S Clark, Mark S Wallac. The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids. Journal of the National Cancer Institute. Monographs. vol 2021. issue 58. 2021-12-01. PMID:34850897. |
cannabis and cannabinoids are increasingly being accessed and used by patients with advanced cancer for various symptoms and general quality of life. |
2021-12-01 |
2023-08-13 |
Not clear |
| Michelle Sexton, Jose M Garcia, Aminah Jatoi, Carey S Clark, Mark S Wallac. The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids. Journal of the National Cancer Institute. Monographs. vol 2021. issue 58. 2021-12-01. PMID:34850897. |
this conference report from the national cancer institute's "cannabis, cannabinoid and cancer research symposium" on the topic of "cancer symptom/treatment side effect management" is an expert perspective of cannabis intervention for cancer and cancer treatment-related symptoms. |
2021-12-01 |
2023-08-13 |
Not clear |